ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1

Jűrgen Floege; Sean J. Barbour; Daniel C. Cattran; Jonathan J. Hogan; Patrick H. Nachman; Sydney C.W. Tang; Jack F.M. Wetzels; Michael Cheung; David C. Wheeler; Wolfgang C. Winkelmayer; Brad H. Rovin

doi:10.36485/1561-6274-2020-24-2-22-41

ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1

Translated title of the contribution: MANAGEMENT AND TREATMENT OF GLOMERULAR DISEASES (PART 1): CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE

Jűrgen Floege, Sean J. Barbour, Daniel C. Cattran, Jonathan J. Hogan, Patrick H. Nachman, Sydney C.W. Tang, Jack F.M. Wetzels, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Brad H. Rovin

Medicine - Renal and Hypertension Division

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline’s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

Translated title of the contribution	MANAGEMENT AND TREATMENT OF GLOMERULAR DISEASES (PART 1): CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE
Original language	Russian
Pages (from-to)	22-41
Number of pages	20
Journal	Nephrology (Saint-Petersburg)
Volume	24
Issue number	2
DOIs	https://doi.org/10.36485/1561-6274-2020-24-2-22-41
State	Published - 2020

Bibliographical note

Funding Information:
The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Achillion, Aurinia Pharmaceuticals, Calliditas Therapeutics, Chemo-Centryx, Chugai, Expedition Therapeutics, Gilead, Goldfinch Bio, Kyowa Kirin, Mallinckrodt Pharmaceuticals, Novartis, Omeros, Sanofi Genzyme, and Vifor Fresenius Medical Care Renal Pharma.

Publisher Copyright:
© 2020 The Author(s).

Keywords

IgA nephropathy
KDIGO
hypertension
kidney biopsy
membranous nephropathy
proteinuria

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.36485/1561-6274-2020-24-2-22-41

OpenUrl availability

Full text

Cite this

Floege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., Wetzels, J. F. M., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., & Rovin, B. H. (2020). ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1. Nephrology (Saint-Petersburg), 24(2), 22-41. https://doi.org/10.36485/1561-6274-2020-24-2-22-41

ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1. / Floege, Jűrgen; Barbour, Sean J.; Cattran, Daniel C. et al.
In: Nephrology (Saint-Petersburg), Vol. 24, No. 2, 2020, p. 22-41.

Research output: Contribution to journal › Article › peer-review

Floege, J, Barbour, SJ, Cattran, DC, Hogan, JJ, Nachman, PH, Tang, SCW, Wetzels, JFM, Cheung, M, Wheeler, DC, Winkelmayer, WC & Rovin, BH 2020, 'ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1', Nephrology (Saint-Petersburg), vol. 24, no. 2, pp. 22-41. https://doi.org/10.36485/1561-6274-2020-24-2-22-41

@article{402cc537c7f04fe0bcd19de36e8b14e1,

title = "ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1",

abstract = "The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline{\textquoteright}s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.",

keywords = "IgA nephropathy, KDIGO, hypertension, kidney biopsy, membranous nephropathy, proteinuria",

author = "J{\H u}rgen Floege and Barbour, {Sean J.} and Cattran, {Daniel C.} and Hogan, {Jonathan J.} and Nachman, {Patrick H.} and Tang, {Sydney C.W.} and Wetzels, {Jack F.M.} and Michael Cheung and Wheeler, {David C.} and Winkelmayer, {Wolfgang C.} and Rovin, {Brad H.}",

note = "Funding Information: The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Achillion, Aurinia Pharmaceuticals, Calliditas Therapeutics, Chemo-Centryx, Chugai, Expedition Therapeutics, Gilead, Goldfinch Bio, Kyowa Kirin, Mallinckrodt Pharmaceuticals, Novartis, Omeros, Sanofi Genzyme, and Vifor Fresenius Medical Care Renal Pharma. Publisher Copyright: {\textcopyright} 2020 The Author(s).",

year = "2020",

doi = "10.36485/1561-6274-2020-24-2-22-41",

language = "Russian",

volume = "24",

pages = "22--41",

journal = "Nephrology (Saint-Petersburg)",

issn = "1561-6274",

publisher = "Eskulap",

number = "2",

}

TY - JOUR

T1 - ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ

T2 - ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1

AU - Floege, Jűrgen

AU - Barbour, Sean J.

AU - Cattran, Daniel C.

AU - Hogan, Jonathan J.

AU - Nachman, Patrick H.

AU - Tang, Sydney C.W.

AU - Wetzels, Jack F.M.

AU - Cheung, Michael

AU - Wheeler, David C.

AU - Winkelmayer, Wolfgang C.

AU - Rovin, Brad H.

N1 - Funding Information: The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Achillion, Aurinia Pharmaceuticals, Calliditas Therapeutics, Chemo-Centryx, Chugai, Expedition Therapeutics, Gilead, Goldfinch Bio, Kyowa Kirin, Mallinckrodt Pharmaceuticals, Novartis, Omeros, Sanofi Genzyme, and Vifor Fresenius Medical Care Renal Pharma. Publisher Copyright: © 2020 The Author(s).

PY - 2020

Y1 - 2020

N2 - The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline’s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

AB - The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline’s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

KW - IgA nephropathy

KW - KDIGO

KW - hypertension

KW - kidney biopsy

KW - membranous nephropathy

KW - proteinuria

UR - http://www.scopus.com/inward/record.url?scp=85115084567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115084567&partnerID=8YFLogxK

U2 - 10.36485/1561-6274-2020-24-2-22-41

DO - 10.36485/1561-6274-2020-24-2-22-41

M3 - Article

AN - SCOPUS:85115084567

SN - 1561-6274

VL - 24

SP - 22

EP - 41

JO - Nephrology (Saint-Petersburg)

JF - Nephrology (Saint-Petersburg)

IS - 2

ER -

ПРИНЦИПЫ ВЕДЕНИЯ ГЛОМЕРУЛЯРНЫХ БОЛЕЗНЕЙ: ИТОГИ СОГЛАСИТЕЛЬНОЙ КОНФЕРЕНЦИИ KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO). ЧАСТЬ 1

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this